Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension

Irene Lang, Bernhard C Meyer, Takeshi Ogo, Hiromi Matsubara, Marcin Kurzyna, Hossein-Ardeschir Ghofrani, Eckhard Mayer, Philippe Brenot, Irene Lang, Bernhard C Meyer, Takeshi Ogo, Hiromi Matsubara, Marcin Kurzyna, Hossein-Ardeschir Ghofrani, Eckhard Mayer, Philippe Brenot

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is thought to result from incomplete resolution of pulmonary thromboemboli that undergo organisation into fibrous tissue within pulmonary arterial branches, filling pulmonary arterial lumina with collagenous obstructions. The treatment of choice is pulmonary endarterectomy (PEA) in CTEPH centres, which has low post-operative mortality and good long-term survival. For patients ineligible for PEA or who have recurrent or persistent pulmonary hypertension after surgery, medical treatment with riociguat is beneficial. In addition, percutaneous balloon pulmonary angioplasty (BPA) is an emerging option, and promises haemodynamic and functional benefits for inoperable patients. In contrast to conventional angioplasty, BPA with undersized balloons over guide wires exclusively breaks intraluminal webs and bands, without dissecting medial vessel layers, and repeat sessions are generally required. Observational studies report that BPA improves haemodynamics, symptoms and functional capacity in patients with CTEPH, but controlled trials with long-term follow-up are needed. Complications include haemoptysis, wire injury, vessel dissection, vessel rupture, reperfusion pulmonary oedema, pulmonary parenchymal bleeding and haemorrhagic pleural effusions. This review summarises the available evidence for BPA, patient selection, recent technical refinements and periprocedural imaging, and discusses the potential future role of BPA in the management of CTEPH.

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside this article at err.ersjournals.com

Copyright ©ERS 2017.

Figures

FIGURE 1
FIGURE 1
a) Pulmonary angiography, showing a stenosis in the subsegment of the 10th segmental artery (anterior view); b) the catheter is introduced into a web stenosis; c) the wire is introduced between the fibrotic material and the balloon is inflated, leading to rupture of the web. d) Angiography after balloon pulmonary angioplasty shows an improvement of blood flow with better perfusion of the parenchyma and quick venous return. In contrast to pulmonary endarterectomy, the fibrous material is not removed from the arteries, but is crushed against the vessel wall.
FIGURE 2
FIGURE 2
Pulmonary arterial imaging before and after percutaneous balloon pulmonary angioplasty (BPA). a) Pre-procedure pulmonary angiogram demonstrating an intra-arterial fibrous “web” lesion; b) the corresponding intravascular ultrasound image showing the intravascular filling defect; c) the BPA balloon in place; d) pulmonary angiogram after the BPA procedure, showing the patent arterial lumen.
FIGURE 3
FIGURE 3
a–d) Selective angiograms and e–h) digital-subtraction angiograms of the right and left pulmonary arteries in a 76-year-old female with chronic thromboembolic pulmonary hypertension manifestation at the level of segmental and subsegmental branching. e–h) Image acquisition in the digital-subtraction angiography technique in frontal or lateral (90° left anterior oblique) projection using intra-arterial contrast injection (iomeprol 300 mg iodine·mL−1, flow rate 12 mL·s−1, volume per injection 35 mL, frame rate 7.5·s-1).
FIGURE 4
FIGURE 4
a) Conventional pulmonary angiogram, with b) and c) corresponding optical coherence tomography images from a patient with chronic thromboembolic pulmonary hypertension, showing the nature of vascular obstructions at two locations. #: location for b); ¶: location for c). Scale bars=1 mm.

References

    1. Galiè N, Humbert M, Vachiery JL, et al. . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J 2015; 46: 903–975.
    1. Banks DA, Pretorius GV, Kerr KM, et al. . Pulmonary endarterectomy: part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Semin Cardiothorac Vasc Anesth 2014; 18: 319–330.
    1. Fedullo P, Kerr KM, Kim NH, et al. . Chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2011; 183: 1605–1613.
    1. Kim NH. Group 4 pulmonary hypertension. Chronic thromboembolic pulmonary hypertension: epidemiology, pathophysiology, and treatment. Cardiol Clin 2016; 34: 435–441.
    1. Lang IM, Dorfmüller P, Vonk Noordegraaf A. The pathobiology of chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc 2016; 13 Suppl 3: S215–S221.
    1. Wagenvoort CA. Pathology of pulmonary thromboembolism. Chest 1995; 107: 10S–17S.
    1. Delcroix M, Lang I, Pepke-Zaba J, et al. . Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation 2016; 133: 859–871.
    1. Jenkins D, Mayer E, Screaton N, et al. . State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management. Eur Respir Rev 2012; 21: 32–39.
    1. Kurzyna M, Darocha S, Koteja A, et al. . Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Postepy Kardiol Interwencyjnej 2015; 11: 1–4.
    1. Jenkins D. Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2015; 24: 263–271.
    1. Jenkins D, Madani M, Fadel E, et al. . Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26: 160111.
    1. Freed DH, Thomson BM, Berman M, et al. . Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 2011; 141: 383–387.
    1. Mayer E, Jenkins D, Lindner J, et al. . Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702–710.
    1. Ghofrani HA, D'Armini AM, Grimminger F, et al. . Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013; 369: 319–329.
    1. Feinstein JA, Goldhaber SZ, Lock JE, et al. . Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 2001; 103: 10–13.
    1. Kataoka M, Inami T, Hayashida K, et al. . Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012; 5: 756–762.
    1. Sugimura K, Fukumoto Y, Satoh K, et al. . Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76: 485–488.
    1. Andreassen AK, Ragnarsson A, Gude E, et al. . Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart 2013; 99: 1415–1420.
    1. Fukui S, Ogo T, Morita Y, et al. . Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 2014; 43: 1394–1402.
    1. Shimura N, Kataoka M, Inami T, et al. . Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol 2015; 183: 138–142.
    1. Inami T, Kataoka M, Shimura N, et al. . Pressure-wire-guided percutaneous transluminal pulmonary angioplasty: a breakthrough in catheter-interventional therapy for chronic thromboembolic pulmonary hypertension. JACC Cardiovasc Interv 2014; 7: 1297–1306.
    1. Inami T, Kataoka M, Ando M, et al. . A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS One 2014; 9: e94587.
    1. Yanagisawa R, Kataoka M, Inami T, et al. . Safety and efficacy of percutaneous transluminal pulmonary angioplasty in elderly patients. Int J Cardiol 2014; 175: 285–289.
    1. Velázquez Martín M, Albarrán González-Trevilla A, Alonso Charterina S, et al. . Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Preliminary experience in Spain in a series of 7 patients. Rev Esp Cardiol 2015; 68: 535–537.
    1. Roik M, Wretowski D, Łabyk A, et al. . Refined balloon pulmonary angioplasty driven by combined assessment of intra-arterial anatomy and physiology – multimodal approach to treated lesions in patients with non-operable distal chronic thromboembolic pulmonary hypertension – technique, safety and efficacy of 50 consecutive angioplasties. Int J Cardiol 2016; 203: 228–235.
    1. Aoki T, Sugimura K, Nochioka K, et al. . Effects of balloon pulmonary angioplasty on oxygenation in patients with chronic thromboembolic pulmonary hypertension – importance of intrapulmonary shunt. Circ J 2016; 80: 2227–2234.
    1. Kawakami T, Ogawa A, Miyaji K, et al. . Novel angiographic classification of each vascular lesion in chronic thromboembolic pulmonary hypertension based on selective angiogram and results of balloon pulmonary angioplasty. Circ Cardiovasc Interv 2016; 9: e003318.
    1. Kimura M, Kohno T, Kawakami T, et al. . Balloon pulmonary angioplasty attenuates ongoing myocardial damage in patients with chronic thromboembolic pulmonary hypertension. Int J Cardiol 2016; 207: 387–389.
    1. Koike H, Sueyoshi E, Sakamoto I, et al. . Quantification of lung perfusion blood volume (lung PBV) by dual-energy CT in patients with chronic thromboembolic pulmonary hypertension (CTEPH) before and after balloon pulmonary angioplasty (BPA): preliminary results. Eur J Radiol 2016; 85: 1607–1612.
    1. Ogo T, Fukuda T, Tsuji A, et al. . Efficacy and safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension guided by cone-beam computed tomography and electrocardiogram-gated area detector computed tomography. Eur J Radiol 2017; 89: 270–276.
    1. Tsugu T, Murata M, Kawakami T, et al. . Changes in right ventricular dysfunction after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Am J Cardiol 2016; 118: 1081–1087.
    1. Yamasaki Y, Nagao M, Abe K, et al. . Balloon pulmonary angioplasty improves interventricular dyssynchrony in patients with inoperable chronic thromboembolic pulmonary hypertension: a cardiac MR imaging study. Int J Cardiovasc Imaging 2017; 33: 229–239.
    1. Tsuji A, Ogo T, Ueda J, et al. . Predictors of residual pulmonary hypertension after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Int J Cardiol 2017; 226: 118–120.
    1. Kopeć G, Stępniewski J, Waligóra M, et al. . Staged treatment of central and peripheral lesions in chronic thromboembolic pulmonary hypertension. Pol Arch Med Wewn 2016; 126: 97–99.
    1. Taniguchi Y, Miyagawa K, Nakayama K, et al. . Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. EuroIntervention 2014; 10: 518–525.
    1. Broch K, Murbraech K, Ragnarsson A, et al. . Echocardiographic evidence of right ventricular functional improvement after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2016; 35: 80–86.
    1. Sato H, Ota H, Sugimura K, et al. . Balloon pulmonary angioplasty improves biventricular functions and pulmonary flow in chronic thromboembolic pulmonary hypertension. Circ J 2016; 80: 1470–1477.
    1. Tsugu T, Murata M, Kawakami T, et al. . Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertension. Am J Cardiol 2015; 115: 256–261.
    1. Takei M, Kataoka M, Kawakami T, et al. . Respiratory function and oxygenation after balloon pulmonary angioplasty. Int J Cardiol 2016; 212: 190–191.
    1. Kim NH, Delcroix M, Jenkins DP, et al. . Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62: D92–D99.
    1. Collaud S, Brenot P, Mercier O, et al. . Rescue balloon pulmonary angioplasty for early failure of pulmonary endarterectomy: the earlier the better? Int J Cardiol 2016; 222: 39–40.
    1. Inami T, Kataoka M, Shimura N, et al. . Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv 2013; 6: 725–736.
    1. Mizoguchi H, Ogawa A, Munemasa M, et al. . Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012; 5: 748–755.
    1. Ogawa A, Matsubara H. Balloon pulmonary angioplasty: a treatment option for inoperable patients with chronic thromboembolic pulmonary hypertension. Front Cardiovasc Med 2015; 2: 4.
    1. Auger WR, Fedullo PF, Moser KM, et al. . Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992; 182: 393–398.
    1. Kawakami T, Kataoka M, Arai T, et al. . Retrograde approach in balloon pulmonary angioplasty: useful novel strategy for chronic total occlusion lesions in pulmonary arteries. JACC Cardiovasc Interv 2016; 9: e19–e20.
    1. Geschka S, Kretschmer A, Sharkovska Y, et al. . Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats. PLoS One 2011; 6: e21853.
    1. Ghofrani HA, Humbert M, Langleben D, et al. . Riociguat: mode of action and clinical development in pulmonary hypertension. Chest 2017; 151: 468–480.
    1. Lang M, Kojonazarov B, Tian X, et al. . The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats. PLoS One 2012; 7: e43433.
    1. Schermuly RT, Stasch JP, Pullamsetti SS, et al. . Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J 2008; 32: 881–891.
    1. Sharkovska Y, Kalk P, Lawrenz B, et al. . Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models. J Hypertens 2010; 28: 1666–1675.
    1. Stasch JP, Evgenov OV. Soluble guanylate cyclase stimulators in pulmonary hypertension. Handb Exp Pharmacol 2013; 218: 279–313.
    1. Tsugu T, Murata M, Kawakami T, et al. . Amelioration of right ventricular function after hybrid therapy with riociguat and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Int J Cardiol 2016; 221: 227–229.
    1. Hinrichs JB, Renne J, Hoeper MM, et al. . Balloon pulmonary angioplasty: applicability of C-Arm CT for procedure guidance. Eur Radiol 2016; 26: 4064–4071.
    1. Yanagisawa R, Kataoka M, Inami T, et al. . Efficacy of 360-degree three-dimensional rotational pulmonary angiography to guide percutaneous transluminal pulmonary angioplasty. EuroIntervention 2014; 9: 1483.
    1. Lang IM, Plank C, Sadushi-Kolici R, et al. . Imaging in pulmonary hypertension. JACC Cardiovasc Imaging 2010; 3: 1287–1295.
    1. Fukuda T, Ogo T, Nakanishi N, et al. . Evaluation of organized thrombus in distal pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension using cone-beam computed tomography. Jpn J Radiol 2016; 34: 423–431.
    1. Hinrichs JB, Marquardt S, von Falck C, et al. . Comparison of C-arm computed tomography and digital subtraction angiography in patients with chronic thromboembolic pulmonary hypertension. Cardiovasc Intervent Radiol 2016; 39: 53–63.
    1. D'Armini AM. Diagnostic advances and opportunities in chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2015; 24: 253–262.
    1. Inohara T, Kawakami T, Kataoka M, et al. . Lesion morphological classification by OCT to predict therapeutic efficacy after balloon pulmonary angioplasty in CTEPH. Int J Cardiol 2015; 197: 23–25.
    1. Ikeda N, Kubota S, Okazaki T, et al. . Comparison of intravascular optical frequency domain imaging versus intravascular ultrasound during balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Catheter Cardiovasc Interv 2016; 87: E268–E274.
    1. Horimoto K, Abe K, Ohtani K, et al. . Optical frequency domain imaging of covered stent-graft for pulmonary artery pseudoaneurysm after balloon pulmonary angioplasty. JACC Cardiovasc Interv 2016; 9: 2255–2256.
    1. Giannouli E, Maycher B. Imaging techniques in chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med 2013; 19: 562–574.
    1. Inami T, Kataoka M, Shimura N, et al. . Incidence, avoidance, and management of pulmonary artery injuries in percutaneous transluminal pulmonary angioplasty. Int J Cardiol 2015; 201: 35–37.
    1. Adams A, Fedullo PF. Postoperative management of the patient undergoing pulmonary endarterectomy. Semin Thorac Cardiovasc Surg 2006; 18: 250–256.
    1. Thistlethwaite PA, Kaneko K, Madani MM, et al. . Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg 2008; 14: 274–282.
    1. Takei M, Kataoka M, Kawakami T, et al. . Under-developed bronchial arteries as a risk factor for complications in balloon pulmonary angioplasty. Int J Cardiol 2016; 203: 1016–1017.
    1. Ejiri K, Ogawa A, Matsubara H. Bail-out technique for pulmonary artery rupture with a covered stent in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. JACC Cardiovasc Interv 2015; 8: 752–753.
    1. Hosokawa K, Abe K, Oi K, et al. . Balloon pulmonary angioplasty-related complications and therapeutic strategy in patients with chronic thromboembolic pulmonary hypertension. Int J Cardiol 2015; 197: 224–226.
    1. Smith IR, Rivers JT. Measures of radiation exposure in cardiac imaging and the impact of case complexity. Heart Lung Circ 2008; 17: 224–231.
    1. Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation 2014; 130: 508–518.
    1. Vachiéry JL, Gaine S. Challenges in the diagnosis and treatment of pulmonary arterial hypertension. Eur Respir Rev 2012; 21: 313–320.
    1. Serruys PW, Morice MC, Kappetein AP, et al. . Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961–972.
    1. Kappetein AP, Head SJ, Morice MC, et al. . Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 2013; 43: 1006–1013.
    1. Taboada D, Pepke-Zaba J, Jenkins DP, et al. . Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J 2014; 44: 1635–1645.
    1. Wiedenroth CB, Liebetrau C, Breithecker A, et al. . Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2016; 35: 591–596.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir